Herceptin Biosimilar Market - (By Application - Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma Market By End Users- Hospital & Clinics, Oncology Centers) - Global Industry Size, Share, Trends, and Forecast, 2018-2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 150

Introduction

Herceptin is the cancer medication used in the treatment of the breast cancer. It is monoclonal antibodies and are used along with the chemotherapy drugs. It is also termed as a targeted therapy drug. Trastuzumab is the one of the brand name herceptin which is administered by slow injection to a vein. In 2014, herceptin has lost the patent in Japan and Europe which has opened the gates for the development of the biosimilar to enter the market.  Whereas, the patent for the drug in U.S. will expire in 2019. The companies are continuously trying to introduce the new generic drugs to expand their market.

Market Dynamics

During last few years, there is a significant rise in the cancer patient pool. Increasing prevalence of the cancer and increasing demand for the targeted therapy have led to drive the growth of the market. Breast cancer is the most widely occurred cancer in the woman. According to the U.S. breast cancer Statistics, over 12.4% of the total American woman develops breast cancer in their lifetime. Changing lifestyle, increasing pollution and adoption of smoking by the people has fuelled the growth of the market. As there are huge opportunity for the development of the cancer drug a number of companies are continuously investing a huge amount of capital in research and development. Increasing spending on research & development and increasing demand for the better drugs for the treatment has supported and created a huge opportunity in coming future.

On the other hand, availability of the alternative treatment and huge side effects of the drugs may slow the growth of the market during the forecasted period.

Market Classification and Overview

The global herceptin biosimilar market is segment into application, end-user, and region.

On the basis of application, the market is segmented into breast cancer, colorectal cancer, leukemia, lymphoma, and others.

Based on the end-user, the market is segmented into hospital & clinics, oncology centers, and others.

Regional Overview

Geographically, the global herceptin biosimilar market is segmented into : North America, Europe, Asia Pacific (APAC), and Latin America, Middle East & Africa (LAMEA).

Europe dominates the global herceptin biosimilar market owing to the patent expiry of the drug in Europe. In 2014, herceptin biosimilar has lost the patent which has increased the market for the generics of the herceptin. Additionally, introduction of the new generics products in European market and continuous research & development in the drug discovery has boosted the growth of the market in Europe. Asia Pacific holds the second position followed by America. The Asia Pacific herceptin biosimilar market is majorly driven by rapid adoption of the herceptin biosimilar, increasing awareness about the generic products, and huge patient pool. Japan is expected to hold the major share in the market owing to the patient expiry of herceptin in 2014. However, LAMEA holds the last position in the market owing to the limited spending on the healthcare and Research & Development.

Report Coverage

Market

Herceptin Biosimilar Market

Analysis Period

2015 – 2026

Historic Data

2015 – 2016

Base Year

2017

Forecast Data

2018 – 2026

Market Stratification

 Application, End Users, Geography

Regional Scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)

Report Coverage

Market Trends, Drivers, Restraints, Porter's Five Forces Analysis,

Competitive Analysis, Player Profiling, Value Chain Analysis

Market Participants

The global herceptin biosimilar market comprises of some of the major players such as

  • Mylan
  • Biocon
  • Roche
  • others

Currently limited numbers of companies are present in the market. Herceptin was developed by Roche and is still holding the patient in some of the countries. However, the companies like Pfizer, TEVA and others are continuously trying to develop the new generic drugs so as to enter in the market. With the expiry of the patent for the drug in 2019, the herceptin biosimilar market will possess a huge growth.

Market Segmentation

Market By Application

  • Breast Cancer
  • Colorectal Cancer
  • Leukemia
  • Lymphoma
  • Others

Market  By End-User

  • Hospital & Clinics
  • Oncology Centers
  • Others

Market By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

 


Related Reports

Botulinum Toxin Market (By Product: Botulinum Toxin Type B, Botulinum Toxin Type A; By End Use: Therapeutics, Aesthetic) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

According to Acumen Research and Consulting, the global Botulinum Toxin market is expected to grow at noteworthy CAGR around 8 % throughout the forecast period and reach around US$ 7.5 billion by 2026. The imperative quality needs and fresh apps are sustaining competition in the worldwide industry of botulinum toxins. Most businesses invest in studies to identify fresh apps which c

Surgical Instrument Tracking Systems Market (By Product: Services, Software, Hardware; By Technology: RFID, Barcodes; By End Use: Hospitals, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global market of Surgical Instrument Tracking Systems is expected to grow at noteworthy CAGR around 18.6 % throughout the forecast period and reach around US$ 500 million by 2026. Surgical instruments have long been accessible for use in healthcare. Systems for the mo

Aesthetic Medicine Market (By Product: Implants, Anti-wrinkle Products [Dermal Fillers, Botulinum Toxin, Chemical Peel], Energy-based Devices [Aesthetic Laser Devices, Microdermabrasion Devices, Ultrasound Devices, Body Contouring Devices]; By End Use: Home Use, Clinics and Beauty Centers) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Aesthetic Medicine market is expected to grow at noteworthy CAGR around 8.5 % throughout the forecast period and reach around US$ 16.3 billion by 2026. Aesthetic Medicines is a clinical subspecialty and field for scientific research that includes all kinds of m

Viscosupplementation Market (By Application: Single Injection, Three Injection, Five Injection) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction: Viscosupplementation is a treatment that aids in diminishing joint agony and improves the practical state of the osteoarthritic joint. It includes the infusion of a thick liquid called hyaluronate into the knee. Hyaluronic corrosive is found in the gooey synovial liquid that greased up the ligament surfaces and shields the joint from stun. This corrosive is a versatil

Smart Home Healthcare Market (By Technology: Wired, Wireless; By Service: Installation and Repair, Renovation and Customization; By Application: Safety and Security Monitoring, Memory Aids, Nutrition or Diet Monitoring, Fall Prevention and Detection, Health Status Monitoring, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction: Smart home healthcare is intended to help in treatment determination, care in the home. It helps in improving the correspondence between the parental figures and healthcare suppliers. Also, numerous wellbeing conditions, particularly incessant illnesses, could be checked and treated in a home outfitted with fundamental smart home items. The global smar

Hyaluronic Acid Market (By Application: Dermal Fillers, Osteoarthritis [Single Injection, Three Injection, Five Injection], Ophthalmic, Vesicoureteral Reflux) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction: The global hyaluronic acid market size is expected to reach 11.07 billion by the end of year 2026. The market is estimated to grow at a CAGR of 6.6% over the forecast period 2019 to 2026. Hyaluronic acid, otherwise called hyaluronan, is a reasonable, gooey substance that is normally delivered by your body. Its biggest measures are found in you

Cart Summary